Open Access

Potential for drug-drug interaction between vonoprazan and prasugrel on antiplatelet effect assessed by VerifyNow P2Y12 assay in patients with coronary artery disease

Congress Session

About the speaker

Doctor Seiji Koga

Juntendo University Nerima Hospital, Tokyo (Japan)
0 follower

9 more presentations in this session

Ischemic and bleeding events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients: a propensity score-matched analysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)

Thumbnail

Predictors of bleeding in elderly patients with myocardial infarction: data from the real world

Speaker: Doctor S. Alegria (Almada, PT)

Thumbnail

Myocardial infarction with nonobstructive coronary arteries: does aspirin have a place in the treatment of this entity?

Speaker: Doctor J. Ferreira (Coimbra, PT)

Thumbnail

Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome

Speaker: Doctor F. Scudiero (Seriate, IT)

Thumbnail

Potential benefit of ticagrelor monotherapy for patients with hypertension undergoing percutaneous coronary intervention: Insights from the Global Leaders trial

Speaker: Doctor R. Modolo (Campinas, BR)

Thumbnail

Access the full session

Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet

Speakers: Doctor S. Koga, Doctor A. Shimizu, Doctor S. Alegria, Doctor J. Ferreira, Doctor F. Scudiero...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk